1. Identification and validation of signal recognition particle 14 as a prognostic biomarker predicting overall survival in patients with acute myeloid leukemia
   Lingling Shi et al, 2021, BMC Medical Genomics CrossRef
2. Oroxylin A, a natural compound, mitigates the negative effects of TNFα-treated acute myelogenous leukemia cells
   Hui Li et al, 2018, Carcinogenesis CrossRef
3. Exploring the mechanism of fraxetin against acute myeloid leukemia through cell experiments and network pharmacology
   Tingting Fang et al, 2024, BMC Complementary Medicine and Therapies CrossRef